Nazometan nasal spray (momentasone furoate (micronized))
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Sinil Pharmaceutical Co., Ltd.
MFDS item code 201904800 · Notified 2019.07.17 · Insurance code 653805501
Relief and prevention of symptoms of allergic rhinitis (seasonal, perennial) and nasal sinusitis, nasal polyps.
This medicine is used for the prevention and treatment of seasonal allergic rhinitis and perennial rhinitis symptoms in adults and children aged 2 years and older. In particular, patients with moderate to severe seasonal allergic rhinitis can start preventive therapy 2-4 weeks before expected allergen exposure. Additionally, it is used for the treatment of nasal polyps in adults aged 18 years and older, and is effective for the treatment of acute sinusitis without severe bacterial infection in adults and adolescents aged 12 years and older. In summary, it is widely used for the treatment of allergic rhinitis, nasal polyps, and acute sinusitis.
1. Allergic Rhinitis Adults (including elderly) and adolescents aged 12 years and older: Generally, spray twice in each nostril once a day (total daily dose 0.2 mg). Once symptoms are alleviated, maintenance dosing may be reduced to spraying once in each nostril once a day (total daily dose 0.1 mg). If symptoms remain unchanged, the dose can be increased to a maximum of four sprays in each nostril once a day (total daily dose 0.4 mg).
Children aged 2 to 11 years: Generally, spray once in each nostril once a day (total daily dose 0.1 mg).
This drug should not be used in certain patients. For example, patients who are allergic to this drug or its components, or those with untreated infections in the nasal mucosa should not use this drug. Additionally, patients who have recently undergone nasal surgery or have wounds in the nasal area should wait until the wounds are completely healed before using this drug. This drug is not for use in children under 2 years of age. This drug should be used with caution in some patients. Patients with active tuberculosis or untreated systemic infections, those who frequently experience nosebleeds, patients who may have been exposed to chickenpox or measles, and pregnant or nursing women should be particularly cautious when using this drug. Its effectiveness is not certain in patients with nasal polyps or those with completely blocked nasal passages, so caution is advised. Various side effects can occur when using this drug. Headache, cold-like symptoms, sore throat, nosebleeds, cough, and upper respiratory infections have been commonly reported, and some patients may experience skin rashes or irritation of the nasal mucosa. Rarely, serious allergic reactions such as bronchospasm or difficulty breathing may occur, so if symptoms occur, usage should be stopped immediately and healthcare professionals should be consulted. Long-term or high-dose use of this drug may lead to systemic corticosteroid effects, so caution is necessary. Particularly, when switching to this drug from systemic steroid treatment, symptoms of adrenal insufficiency may occur, and instructions from healthcare professionals should be followed. While using this drug, fungal infections in the nasal or pharyngeal area may occur, so appropriate treatment is necessary if infection symptoms appear. Additionally, regular monitoring is needed to observe changes in the nasal mucosa during long-term use. Pregnant or nursing women should carefully consider the risks and benefits of using this drug, as it may affect the fetus or infant, and must consult with their healthcare provider. When using this drug in children, there may be a slowdown in growth rate, so regular monitoring of growth status is recommended, and treatment should be carried out at the lowest possible dose. Elderly patients may have reduced physical function, so careful observation of their condition when using this drug is required. If this drug is used in excessive amounts, specific treatment may not be necessary; however, in cases of overuse, systemic steroid side effects may occur, so caution is advised. Before use, shake the container well and perform a spray test to ensure even spraying, and be careful not to spray directly into the eyes or nasal septum during use. This drug should be kept out of reach of children, and its effects on driving or operating machinery are unknown.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, ulcers in the nose, nasal and oral candidiasis, symptoms of anaphylaxis (difficulty breathing, systemic flushing, angioedema, hives), liver dysfunction (liver enzyme abnormalities, elevated ALT, elevated AST, increased serum bilirubin, increased alkaline phosphatase), elevated blood pressure and severe edema, severe edema or urinary abnormalities,
Headache, viral infection, pharyngitis, nosebleeds/bloody mucus, cough, upper respiratory infection, menstrual disorders, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, ear pain, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, fatigue, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort), positive fungal test of the nose,
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The optimal storage temperature is between 2 degrees Celsius and 25 degrees Celsius.
A white or almost white opaque suspension dispensed in a container that delivers a specific amount as a nasal spray.
18 grams/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Hanlim Pharmaceutical Co., Ltd.
Mometasone Furoate Micronized 0.5mg
Suspension · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
(Co., Ltd.) Bynex
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Huons Meditech Co., Ltd.
Mometasone Furoate Micronized 0.5mg
Nasal spray · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.